Contrasting Evidence to Reimbursement Reality for Off-Label Use (OLU) of Drug Treatments in Cancer Care: Rationale and Design of the CEIT-OLU Project

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2019-000596
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Reasons for and Frequency of Off - Label Drug Use

Medicinski Pregled
Medicine
2015English

Off-Label Drug Use in Hospitalized Children

Archives of Pediatrics & Adolescent Medicine
2007English

Evidence for the Off-Label Use of Methylphenidate for Cognitive Enhancement in Healthy Individuals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Off-Label and Unlicensed Drug Use in Ayder Comprehensive Specialized Hospital Neonatal Intensive Care Unit

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2020English

Knowledge and Behaviour of the Pharmacist in the Face of Use Off Label Drug

Visão Acadêmica
2013English

Off-Label Drug Use in Oncology: A Systematic Review of Literature

Journal of Clinical Pharmacy and Therapeutics
Pharmacology
2017English

Search Strategies to Identify Reports on “Off-Label” Drug Use in EMBASE

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2012English

Available Evidence and Outcome of Off-Label Use of Rituximab in Clinical Practice

European Journal of Clinical Pharmacology
MedicinePharmacology
2013English

Trends in Off-Label Drug Use in Ambulatory Settings: 2006–2015

Pediatrics
Child HealthPediatricsPerinatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy